|
|
Volumn 36, Issue 4, 2002, Pages 492-498
|
|
Cardiotoxicity and prescription of thioridazine in New Zealand
a
|
|
Author keywords
Antipsychotic; Arrythmia; Cardiotoxicity; Thioridazine
|
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
DROPERIDOL;
FLUPENTIXOL DECANOATE;
FLUPHENAZINE;
FLUPHENAZINE DECANOATE;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
LEVOMEPROMAZINE;
LOXAPINE SUCCINATE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERICIAZINE;
PIMOZIDE;
PIPOTIAZINE PALMITATE;
POTASSIUM CHANNEL;
POTASSIUM CHANNEL BLOCKING AGENT;
QUETIAPINE;
RISPERIDONE;
THIORIDAZINE;
TIOTIXENE;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRIFLUOPERAZINE;
ARTICLE;
AUSTRALIA;
CARDIOTOXICITY;
CONTROLLED STUDY;
DRUG INDICATION;
GOVERNMENT;
HEALTH CARE POLICY;
HEART ARRHYTHMIA;
HUMAN;
INCIDENCE;
MEDICAL LITERATURE;
NEW ZEALAND;
NORTH AMERICA;
PRESCRIPTION;
PSYCHOSIS;
QT INTERVAL;
RISK ASSESSMENT;
RISK FACTOR;
UNITED KINGDOM;
ANTIPSYCHOTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
LONG QT SYNDROME;
NEW ZEALAND;
PSYCHOTIC DISORDERS;
RISK FACTORS;
THIORIDAZINE;
|
|
EID: 0036689493
PISSN: 00048674
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1440-1614.2002.01045.x Document Type: Article |
|
Times cited : (11)
|
|
References (23)
|
